The overall objectives of this research are to develop methods (1) for estimating vaccine efficacy and effectiveness in the field and (2) for characterizing complex and long-term properties of vaccination in individuals and populations.
The specific aims are 1. To continue development of study designs and methods of analysis for using validation samples to correct for misclassified or partially observed outcomes and missing data in vaccine studies. The goal is improved estimates of protective vaccine efficacy, VES, and vaccine efficacy for infectiousness, VEI, as well as designs for efficient, cost-effective studies. 2. To continue development of cluster-randomized designs to evaluate indirect, total, and overall effectiveness of vaccination strategies. This includes methods for optimal spatial randomization constraints. A new stepped wedge study using longitudinal and cross-sectional carriage studies as baseline data will be developed. The new mini-community design to evaluate indirect effects will be developed in which the cluster is a household or other small transmission unit. 3. To develop methods for joint estimation of the protective effects of vaccination, VES and vaccine efficacy for infectiousness, VEI from households embedded within clusters in a cluster-randomized trial. 4. To develop methods to evaluate immunological correlates of protection that combine models accounting for exposure to infection with approaches delineating different degrees of confidence about the correlate. 5. To continue to explore interpretation of the protective effects of vaccination, VES, when combining results across studies in different populations, taking into account different levels of baseline transmission and pre-existing immunity. This includes developing methods for evaluating vaccine efficacy when a vaccine puts evolutionary pressure on the composition of the population of circulating strains. Statistical approaches to be developed include likelihood inference, Bayesian methods, semiparametric methods, hierarchical models, and survival methods. These methods will be motivated by the design and analysis of studies of influenza, pneumococcal, meningococcal A, rotavirus, and malaria transmission blocking vaccines.
The overall objectives of this research are to develop statistical and epidemiologic methods (1) for estimating vaccine efficacy and effectiveness in the field and (2) for characterizing complex and long-term properties of vaccination in individuals and populations. Our research is motivated by influenza, meningococcal A, pneumococcal, rotavirus, and malaria vaccine field studies on several continents.
|Feldstein, Leora R; Matrajt, Laura; Elizabeth Halloran, M et al. (2016) Extrapolating theoretical efficacy of inactivated influenza A/H5N1 virus vaccine from human immunogenicity studies. Vaccine 34:3796-802|
|Dean, Natalie E; Halloran, M Elizabeth; Yang, Yang et al. (2016) Transmissibility and Pathogenicity of Ebola Virus: A Systematic Review and Meta-analysis of Household Secondary Attack Rate and Asymptomatic Infection. Clin Infect Dis 62:1277-86|
|Rojas, Diana Patricia; Dean, Natalie E; Yang, Yang et al. (2016) The epidemiology and transmissibility of Zika virus in Girardot and San Andres island, Colombia, September 2015 to January 2016. Euro Surveill 21:|
|Gabriel, Erin E; Daniels, Michael J; Halloran, M Elizabeth (2016) Comparing biomarkers as trial level general surrogates. Biometrics 72:1046-1054|
|Feldstein, Leora R; Ellis, Esther M; Rowhani-Rahbar, Ali et al. (2016) The First Reported Outbreak of Chikungunya in the U.S. Virgin Islands, 2014-2015. Am J Trop Med Hyg 95:885-889|
|Gessner, Bradford D; Halloran, M Elizabeth; Khan, Imran (2015) The case for a typhoid vaccine probe study and overview of design elements. Vaccine 33 Suppl 3:C30-5|
|Yang, Y; Zhang, Y; Fang, L et al. (2015) Household transmissibility of avian influenza A (H7N9) virus, China, February to May 2013 and October 2013 to March 2014. Euro Surveill 20:21056|
|Chao, D L; Park, J K; Marks, F et al. (2015) The contribution of neighbours to an individual's risk of typhoid outcome. Epidemiol Infect 143:3520-7|
|Lessler, J; Edmunds, W J; Halloran, M E et al. (2015) Seven challenges for model-driven data collection in experimental and observational studies. Epidemics 10:78-82|
|Schwartz, Lauren M; Halloran, M Elizabeth; Durbin, Anna P et al. (2015) The dengue vaccine pipeline: Implications for the future of dengue control. Vaccine 33:3293-8|
Showing the most recent 10 out of 29 publications